TAL
KDNY

TIG Advisors LLC’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

TIG Advisors LLC’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-893,435
Closed -$34.3M – 66
2023
Q2 		$34.3M Buy
+893,435
New +$22.9M 1.92% 17

TIG Advisors LLC's KDNY Position: Q3 2023 in Review

TIG Advisors LLC sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 893,435 shares — an estimated $34.3M sold.

TIG Advisors LLC first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $34.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

  • TIG Advisors LLC reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • TIG Advisors LLC sold 893,435 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $34.3M.
  • TIG Advisors LLC first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • TIG Advisors LLC's Chinook Therapeutics, Inc. Common Stock position peaked at $34.3M in Q2 2023.
  • 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on TIG Advisors LLC's 13F filing for Q3 2023, filed 14 Nov 2023.